Loading...
Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
OBJECTIVE: Widespread implementation of cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) in clinical settings requires improved accuracy for diagnosis of prodromal disease and for distinguishing AD from non‐AD dementias. Novel and promising CSF biomarkers include neurogranin, a...
Saved in:
| Published in: | Ann Clin Transl Neurol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4704480/ https://ncbi.nlm.nih.gov/pubmed/26783546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.266 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|